envellomedical Profile Banner
Envello Medical Profile
Envello Medical

@envellomedical

Followers
4
Following
1
Media
42
Statuses
48

The first miniaturized, scalable, non-invasive, wireless tissue oximeter for monitoring high-volume chronic diseases.

Richmond, VA
Joined November 2024
Don't wanna be here? Send us removal request.
@envellomedical
Envello Medical
1 day
Every year, 12M people worldwide experience a stroke. On #WorldStrokeDay, we raise awareness of the risks and importance of early action. Learn more from @WorldStrokeOrg: https://t.co/GST7z88Daw
0
0
1
@envellomedical
Envello Medical
10 days
Our COO Dan Rodenhaver is heading to San Francisco for @crfheart's #TCT2025, where he’ll connect with industry peers and share our latest work in advancing real-time perfusion monitoring to improve outcomes for patients. https://t.co/B5wj4sWHJ7
0
0
0
@envellomedical
Envello Medical
15 days
Too often, patient decompensation is detected after perfusion is already compromised. At Envello, our mission is to develop tools that support clinicians across the entire patient journey and help them act sooner. Learn more on our website: https://t.co/7EWtdOzf7e
0
0
0
@envellomedical
Envello Medical
1 month
@JasonKatzMD (NYU) joined our CEO Casey Boutwell & COO Dan Rodenhaver on Episode 5 of Perfusion Musings to discuss predictive medicine in cardiovascular care and the role of real-time perfusion monitoring in heart failure & critical care: https://t.co/ecv8LNlCGH
0
1
1
@envellomedical
Envello Medical
1 month
As our CCO Dan Rodenhaver arrives at #SCAISHOCK this weekend, we are revisiting our chat with @davebaran, one of the architects of the SCAI SHOCK Classification System, a global standard for assessing risk, predicting outcomes, and guiding treatment: https://t.co/4IPQ8JpRVO
0
0
1
@envellomedical
Envello Medical
1 month
Our CCO Dan Rodenhaver is heading to Tampa this week for @SCAI SHOCK 2025, where leaders in cardiogenic shock care will explore early recognition, ICU management, treatment strategies, and the future of AI + novel monitoring. https://t.co/Xnl8ZlSMvJ #SCAISHOCK
0
0
1
@envellomedical
Envello Medical
2 months
September is #AFibAwarenessMonth. AFib raises the risk of stroke and heart failure, but symptoms aren't always obvious. We're developing noninvasive perfusion monitoring designed to give clinicians a clear view of cardiovascular health. https://t.co/HspTipENxO
0
0
0
@envellomedical
Envello Medical
2 months
“We can standardize the process, but it’s still an art form for the patient.” In Ep. 4 of Perfusion Musings, Erin Davis highlights how point-of-care nurses combine data with intuition and shape the future of cardiology. Full episode: https://t.co/TL9T8fmbTw
0
0
0
@envellomedical
Envello Medical
2 months
Cardiogenic shock still carries ~50% mortality. A @JACCJournals review shows macro and micro metrics can diverge. Patients may look stable while perfusion is impaired, and non-invasive tools to capture perfusion more directly could guide care: https://t.co/pAHtULLm9p
0
0
0
@envellomedical
Envello Medical
2 months
In Ep. 4 of Perfusion Musings, we talked with Erin Davis of the University of Utah about how point-of-care nurses are driving better cardiovascular outcomes, and how portable perfusion monitoring can help patients everywhere. Listen: https://t.co/WzugPym037
0
0
0
@envellomedical
Envello Medical
2 months
Nurse-led prevention programs cut major cardiac events by 30% over 5 years, according to a study by @ACCinTouch. Our goal is to support nurses and care teams with tools that have the potential to catch risks earlier and drive better outcomes. Read more: https://t.co/vSLoqScWQl
0
0
0
@envellomedical
Envello Medical
2 months
In Episode 3 of Perfusion Musings, @davebaran talks cardiogenic shock and why the future of medtech must lower patient risk. Watch this clip to hear how noninvasive tools may help clinicians act sooner and save lives: https://t.co/jYSUmzj3wk
0
0
0
@envellomedical
Envello Medical
2 months
Nearly half of US counties have no cardiologist. In rural areas, it’s 86%. At Envello, we’re investing in bold solutions, building portable, noninvasive tech to help frontline clinicians catch cardiovascular risk earlier. More via @CardioBusiness: https://t.co/ATQ6MgJ9Dh
0
0
0
@envellomedical
Envello Medical
3 months
There’s a blind spot in chronic disease management. Standard vitals may leave important details unseen, leading to more invasive measures. We believe continuous tissue perfusion monitoring could offer added insights for clinicians. Learn more: https://t.co/7EWtdOzf7e
0
0
0
@envellomedical
Envello Medical
3 months
Our CEO and CCO were joined by @davebaran, MD, Head of Heart Failure, Transplant and MCS at Cleveland Clinic Florida, on the newest episode of Perfusion Musings to discuss cardiogenic shock and managing patient care in advanced heart failure. Listen: https://t.co/RvsH6Z7tbR
0
0
0
@envellomedical
Envello Medical
3 months
In our second episode of Perfusion Musings, @beaverspharmd shares why interdisciplinary collaboration is more important than ever as cardiovascular care grows more complex and fast-moving innovation reshapes the care landscape. Catch the full episode: https://t.co/lJ2yHNGimr
0
0
0
@envellomedical
Envello Medical
3 months
We launched Perfusion Musings to spark deep conversations around cardiovascular care and perfusion, and we’re grateful for the reception! We’re diving deep this summer with guests like @davebaran, Erin Davis, and @JasonKatzMD. Stay tuned for new episodes: https://t.co/ycV6DOM7Xh
0
0
0
@envellomedical
Envello Medical
3 months
This July, we’re joining @NatForumHDSP in observing a #HeartHealthySummer. We’re advancing noninvasive perfusion monitoring to help clinicians detect cardiovascular stress earlier. Stay safe, stay hydrated, and check with your doctor if you’re at risk.
0
0
0
@envellomedical
Envello Medical
3 months
How do we move from population-based care to truly personalized treatment? In Episode 2 of Perfusion Musings, @beaverspharmd discusses evolving role of pharmacists in cardiovascular care, and why individualized medicine is key to improving outcomes. https://t.co/lJ2yHNGimr
0
0
0
@envellomedical
Envello Medical
3 months
The calibration phase of our clinical trial is officially underway. Thanks to our Director of Research Thibault Roumengous, the Duke team, and our scientific advisory board for helping make this possible. Learn more about our pipeline: https://t.co/tDgdHcdZrC #PerfusionMonitoring
0
0
0